Literature DB >> 19117021

Jakking up tumor registry reporting of the myeloproliferative neoplasms.

H Andrew Selinger, Xiaomei Ma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19117021     DOI： 10.1002/ajh.21333

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  4 in total

1.  Anthropometric, medical history and lifestyle risk factors for myeloproliferative neoplasms in the Iowa Women's Health Study cohort.

Authors:  Alexis D Leal; Carrie A Thompson; Alice H Wang; Robert A Vierkant; Thomas M Habermann; Julie A Ross; Ruben A Mesa; Beth A Virnig; James R Cerhan
Journal:  Int J Cancer       Date:  2013-10-15       Impact factor: 7.396

2.  Changing incidence of myeloproliferative neoplasms: trends and subgroup risk profiles in the USA, 1973-2011.

Authors:  Melissa A Deadmond; Julie A Smith-Gagen
Journal:  J Cancer Res Clin Oncol       Date:  2015-05-13       Impact factor: 4.553

3.  Incidence and patient survival of myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms in the United States, 2001-12.

Authors:  Samer A Srour; Susan S Devesa; Lindsay M Morton; David P Check; Rochelle E Curtis; Martha S Linet; Graça M Dores
Journal:  Br J Haematol       Date:  2016-04-07       Impact factor: 6.998

4.  Patient perspectives of a diagnosis of myeloproliferative neoplasm in a case control study.

Authors:  Mary Frances McMullin; Glen James; Andrew S Duncombe; Frank de Vocht; Lin Fritschi; Mike Clarke; Lesley A Anderson
Journal:  Exp Hematol Oncol       Date:  2016-05-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.